Background Early identification of pregnant women at risk of delivering small-for-gestational-
age (SGA) infants is required to reduce the rates of mortality and morbidity in their whole life …

OBJECTIVE To investigate the relationship between very low maternal serum alpha-
fetoprotein levels (MSAFP), neonatal size, and possible associations with obstetric …

Objective To determine the relationship between adverse pregnancy outcomes and
maternal serum alpha-fetoprotein (MSAFP) levels. Materials and methods A retrospective …

Background It is well known that second-trimester maternal serum alpha-fetoprotein (MS-
AFP) is a predictor for adverse pregnancy outcomes (APOs), such as preterm birth, stillbirth …

OBJECTIVE: We have carried out a systematic review of the association between elevated
second trimester maternal serum alpha-fetoprotein (AFP) and singleton preterm birth in …

Background: Alpha-fetoprotein (AFP) is the major serum protein in the embryonic stage and
in the early fetal stage. The aim of this study was to measure maternal serum AFP levels in …

Aim: The aim of this study was to evaluate the predictive value of α-fetoprotein in maternal
serum (MS-AFP) as a marker for diverse pregnancy outcomes. Methods: The study was …

Objectives: The purpose of this study was to determined the predictive value of maternal
serum alpha-fetoprotein (MSAFP) as a marker for adverse pregnancy outcomes. Material …

Objective The aim of this study was to investigate the overall distribution of pregnancy
outcomes in women with elevated second-trimester maternal serum alpha-fetoprotein (MS …

Fetal growth restriction has been associated with an increased risk of adverse perinatal
outcomes (APOs). We determined the importance of fetal growth detention (FGD) in late …